BASF Ends Bid for Evonik After Two Cash Offers Rejected
Key Facts
German company BASF said on Thursday, November 19, that it would end its efforts to acquire Evonik after the latter rejected two non-binding cash offers, Reuters reported via Euronext. The decision brings an end to an acquisition attempt that began with contacts in September and included improved offers from the larger company. Evonik had rejected the latest offer after its value was raised to more than 11 billion euros, according to a Reuters report on November 17. Reuters reported that BASF had been considering further concessions before announcing it was ending its efforts. The move ends a negotiating process that did not produce an agreement between the two German companies.
BASF began contacting Evonik in September, then made an initial offer of 22.15 euros per share, which Evonik rejected that same month, Reuters reported. In October, BASF improved its offer to 24 euros per share, valuing the company at about 11.18 billion euros, according to a Reuters report published on November 9. The figures show an upward trajectory in the value of the proposals, from the initial offer to the improved one and finally to an offer worth more than 11 billion euros. But the higher financial consideration did not change Evonik’s position, and it also rejected the latest offer. BASF announced no acquisition agreement before ending its efforts.
Evonik’s management had told employees, Reuters reported on November 18, that it was convinced the company had a strong future as an independent entity. The position came as BASF was considering whether it could improve its offer, and one day before it announced it was ending the attempt. North Rhine-Westphalia Premier Hendrik Wüst also voiced the state’s support for the company’s independence, saying: "We stand by our decision that this company should continue to develop independently." Evonik’s rejection of the offer thus coincided with public political support for its continued independence. The reported statements did not announce any change in this position.
Evonik’s 2025 results offer an indication of the scale of the business at the center of the acquisition attempt: the company recorded sales of 14.1 billion euros and adjusted earnings before interest, taxes, depreciation and amortization of 1.9 billion euros. Evonik announced these figures in a statement issued in October. In outlining its acquisition strategy, BASF said deals "can be done, but are not a necessity" as part of its strategy. It added that it would pursue a potential deal only if it increased value for shareholders, and that it "will not overpay." These statements set out a standard BASF said it would apply in evaluating any acquisition, while its effort to acquire Evonik ended without an agreement.
In market moves before the withdrawal was announced, Evonik shares closed up 4.2% in the November 17 session, while BASF shares fell 2.8%, Reuters reported. EL7 data showed that BASF’s American depositary receipts, listed under the ticker BASFY, closed at 14.34 dollars on November 17 and then at 14.1 dollars on November 18. These figures reflect the closes of the two sessions before Thursday’s announcement and do not indicate the stock’s performance after the end of the effort was announced. The available data did not establish a price move in Evonik shares following the withdrawal or attribute one to it. EL7 reported on September 25 that BASF had confirmed it had entered exploratory talks to acquire its competitor.